The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications
- 1 October 2004
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (15), 2217-2229
- https://doi.org/10.1016/j.ejca.2004.07.006
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Altered expression of the ZBRK1 gene in human breast carcinomasThe Journal of Pathology, 2004
- Cbl-mediated Ubiquitinylation Is Required for Lysosomal Sorting of Epidermal Growth Factor Receptor but Is Dispensable for EndocytosisJournal of Biological Chemistry, 2003
- Signal Transduction by the TGF-β SuperfamilyScience, 2002
- Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complexNature, 2002
- Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-β-dependent TranscriptionPublished by Elsevier ,2001
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- Abnormal expression of MDM-2 in breast carcinomasBreast Cancer Research and Treatment, 1996
- The fates of proteins in cellsThe Science of Nature, 1995
- New insights into proteasome function: from archaebacteria to drug developmentChemistry & Biology, 1995
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993